It has been hypothesized that COVID-19 vaccination can activate autoimmune diseases through the production of autoantibodies (e.g., platelet factor 4 antibody-mediated platelet may lead to immune mediated thrombocytopenia). This evidence concerns the gene PF4 and COVID-19.